Results 101 to 110 of about 1,218 (152)

Could Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists Play a Role in Gout Treatment? [PDF]

Pharmaceutics
Kaufmann D, Schlesinger N.
europepmc   +1 more source

Gender Bias in Clinical Trials of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Systematic Review. [PDF]

J Diabetes Res
Lora-Escobar SJ, Rodríguez-de Francisco L, López-Feijoo M, Santos-Ramos B, Bellido V, Casado-Mejía R, Acosta-García H.   +6 more
europepmc   +1 more source

Effects of antidiabetic drugs on the level of serum uric acid in patients who have type 2 diabetes. [PDF]

Saudi Med J
Wang G, Wang G.
europepmc   +1 more source

Impact of Sodium-Glucose Co-Transporter 2 Inhibitors on Atrial Fibrillation Recurrence Post-Catheter Ablation Among Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. [PDF]

J Cardiovasc Electrophysiol
Abdelhadi NA, Ragab KM, Elkholy M, Koneru J, Ellenbogen KA, Pillai A.   +5 more
europepmc   +1 more source

Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS. [PDF]

In Vivo
Ohyama K, Takahashi T, Akiyama S, Hori Y.   +3 more
europepmc   +1 more source

Pharmacological research of a novel selective SGLT2 inhibitor, tofogliflozin

, 2014
openaire   +1 more source

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Trials. [PDF]

Cureus
Ahmed AE, Alhufayyan NS, Qadri HF, Atiah AF, Alhazmi WM, Alhazemi NT, Zalah HA, Nasser FM, Monajid RM, Aljuhani MG.   +9 more
europepmc   +1 more source

Effect of Tofogliflozin on Cardiac Function: Potential Link Between Ketone Bodies and the Heart

Journal of Endocrinology and Metabolism, 2017
openaire   +2 more sources

Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin-a post-hoc analysis of the UTOPIA study. [PDF]

Diabetol Int
Katakami N, Mita T, Sato Y, Watada H, Shimomura I.   +4 more
europepmc   +1 more source

Effectiveness of SGLT2 inhibitors compared to sulphonylureas for long-term glycemic control in type 2 diabetes: A meta-analysis. [PDF]

Biomol Biomed
Zhan Z, Wang J, Shen N, Liu X, Wang L.
europepmc   +1 more source